Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases - Septerna

05.14.25

In The News

Up Next

View All

Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference

No results found.